Therapeutic Plasma Exchange as a Bridge to Spontaneous Recovery in Pediatric Acute Liver Failure in a Resource‐Limited Setting: A Prospective Single‐Center Experience in Morocco

In resource-limited settings where liver transplantation is unavailable, pediatric acute liver failure (PALF) carries a markedly high mortality rate. In this context, extracorporeal liver support systems (ELSS), such as therapeutic plasma exchange (TPE), do not serve as a bridge to transplantation, but rather the sole critical bridge to spontaneous liver recovery. We conducted a prospective single-center study in a pediatric intensive care unit, including seven patients admitted with PALF who underwent TPE. Clinical data, biological markers (including transaminase, bilirubin, INR, and ammonia), and patient outcomes were analyzed to evaluate the biological efficacy of TPE and identify factors influencing survival. All seven patients presented with severe biochemical derangement and advanced hepatic encephalopathy (HE) upon admission. TPE demonstrated significant biological efficacy, consistently reducing hepatic cytolysis and ammonia levels. To further optimize continuous ammonia clearance, one patient underwent continuous venovenous hemodialysis (CVVHD) in conjunction with TPE. Despite these biochemical improvements, clinical outcomes remained poor due to significantly delayed presentations. All patients were admitted at least 2 weeks after symptom onset, largely because jaundice was underestimated and not perceived as a life-threatening symptom. TPE is a biologically effective intervention and a vital bridge to spontaneous liver recovery for PALF in settings without liver transplant capabilities. However, its clinical success is severely limited by delayed hospital admission. The pre-existing and irreversible neurological damage caused by prolonged hyperammonemia ultimately drives mortality. Improving survival rates requires a systemic shift toward early recognition of jaundice and immediate intensive care referral. presentation with advanced neurologic injury. The effects of earlier ALF recognition and referral on outcomes require further investigation.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Apheresis
Published
2026-07-23
DOI
https://doi.org/10.1002/jca.70159
Primary Topic
Liver Disease and Transplantation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Therapeutic Plasma Exchange as a Bridge to Spontaneous Recovery in Pediatric Acute Liver Failure in a Resource‐Limited Setting: A Prospective Single‐Center Experience in Morocco

Mustapha Harandou, Mohamed Adnane Berdaï, Saïd Benlamkaddem, Djoudline Doughmi et al.
Journal of Clinical Apheresis
Liver Disease and Transplantation
article

Therapeutic Plasma Exchange as a Bridge to Spontaneous Recovery in Pediatric Acute Liver Failure in a Resource‐Limited Setting: A Prospective Single‐Center Experience in Morocco

Mustapha Harandou, Mohamed Adnane Berdaï, Saïd Benlamkaddem, Djoudline Doughmi, Imad Daoudi
article en

Abstract

In resource-limited settings where liver transplantation is unavailable, pediatric acute liver failure (PALF) carries a markedly high mortality rate. In this context, extracorporeal liver support systems (ELSS), such as therapeutic plasma exchange (TPE), do not serve as a bridge to transplantation, but rather the sole critical bridge to spontaneous liver recovery. We conducted a prospective single-center study in a pediatric intensive care unit, including seven patients admitted with PALF who underwent TPE. Clinical data, biological markers (including transaminase, bilirubin, INR, and ammonia), and patient outcomes were analyzed to evaluate the biological efficacy of TPE and identify factors influencing survival. All seven patients presented with severe biochemical derangement and advanced hepatic encephalopathy (HE) upon admission. TPE demonstrated significant biological efficacy, consistently reducing hepatic cytolysis and ammonia levels. To further optimize continuous ammonia clearance, one patient underwent continuous venovenous hemodialysis (CVVHD) in conjunction with TPE. Despite these biochemical improvements, clinical outcomes remained poor due to significantly delayed presentations. All patients were admitted at least 2 weeks after symptom onset, largely because jaundice was underestimated and not perceived as a life-threatening symptom. TPE is a biologically effective intervention and a vital bridge to spontaneous liver recovery for PALF in settings without liver transplant capabilities. However, its clinical success is severely limited by delayed hospital admission. The pre-existing and irreversible neurological damage caused by prolonged hyperammonemia ultimately drives mortality. Improving survival rates requires a systemic shift toward early recognition of jaundice and immediate intensive care referral. presentation with advanced neurologic injury. The effects of earlier ALF recognition and referral on outcomes require further investigation.

Journal of Clinical ApheresisVol. 41(4)
Mother Hospital (IN), Centre Hospitalier Universitaire Hassan II (MA)
Openalex Percentile: Top 10%
Liver Disease and Transplantation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.